Six-week oral ketamine treatment for chronic suicidality is associated with increased grey matter volume
Cyrana C. Gallay, Grace Forsyth, Adem Can, Megan Dutton, Daniel Jamieson, Emma Jensen, Daniel F. Hermens, Maxwell R. Bennett, Jim Lagopoulos
Topics & Concepts
GlutamatergicGrey matterPutamenNucleus accumbensKetamineNMDA receptorNeurosciencePsychologyLimbic systemThalamusGlutamate receptorMedicineAnesthesiaInternal medicineCentral nervous systemWhite matterMagnetic resonance imagingReceptorRadiologyTreatment of Major DepressionTryptophan and brain disordersGenetic Neurodegenerative Diseases